Pancreatic beta cell death is a hallmark of type 1 (T1D) and type 2 (T2D) diabetes, but the molecular mechanisms underlying this aspect of diabetic pathology are poorly understood. Here we report that expression of the microRNA (miR)-200 family is strongly induced in islets of diabetic mice and that beta cell-specific overexpression of miR-200 in mice is sufficient to induce beta cell apoptosis and lethal T2D. Conversely, mir-200 ablation in mice reduces beta cell apoptosis and ameliorates T2D. We show that miR-200 negatively regulates a conserved anti-apoptotic and stress-resistance network that includes the essential beta cell chaperone Dnajc3 (also known as p58IPK) and the caspase inhibitor Xiap. We also observed that mir-200 dosage positively controls activation of the tumor suppressor Trp53 and thereby creates a pro-apoptotic gene-expression signature found in islets of diabetic mice. Consequently, miR-200-induced T2D is suppressed by interfering with the signaling of Trp53 and Bax, a proapoptotic member of the B cell lymphoma 2 protein family. Our results reveal a crucial role for the miR-200 family in beta cell survival and the pathophysiology of diabetes.
Adequate insulin secretion from pancreatic beta cells is necessary to maintain blood glucose levels within a physiological range. During the development of T2D, insulin secretion becomes insufficient to normalize blood glucose levels and eventually beta cell death and reduced beta cell mass ensue in both animal models of and human subjects with overt T2D 1, 2 . Apoptosis of beta cells in allogenic islet transplants is also an important factor in the unpredictable durability of these transplants for the treatment of T1D 3 . The molecular underpinnings of diabetic beta cell apoptosis remain poorly understood, although several mechanisms, including inflammation, DNA damage, oxidative and endoplasmatic reticulum stress, have been implicated 2,4-6 . miRs are noncoding RNAs of approximately 22 nucleotides in length that regulate gene expression by inducing degradation and/or translational inhibition of potentially hundreds of target mRNAs 7 . miRs primarily regulate gene expression by binding to the 3′ untranslated region (UTR) of their target mRNA with their 'seed' sequence, which encompasses nucleotides 2-7 of the miR sequence 8 . Our group and others have previously uncovered important metabolic roles for miRs, including in beta cells [9] [10] [11] [12] [13] [14] [15] .
The 17 . Studies in tumor biopsies and cancer cell lines indicate that miR-200 family members may regulate cell differentiation, epithelial-tomesenchymal transition (EMT) and metastasis [18] [19] [20] , whereas a recent study linked miR-200b and miR-429 to female fertility and found no signs of EMT when these two mir-200 family members were ablated in vivo 21 . Previous studies have analyzed miR-200 target gene expression in human islets 22 and provided evidence that miR-200b has a role in beta cell apoptosis in vitro 23 , the latter mediated by Txnip, a protein mediator of the cellular response to oxidative stress. However, the physiological role of the miR-200 family in metabolic regulation and pancreatic beta cell physiology in vivo has not been investigated. In this study we examined the miR-200 family in pancreatic beta cells and studied its impact on beta cell survival in response to metabolic stresses. We found that loss of miR-200 function protects against beta cell apoptosis in genetic and pharmacological mouse models that are relevant to human diabetes.
RESULTS

Increased miR-200c levels induce beta cell apoptosis
We examined expression of miR-200 family members in wild-type (WT) mice and found that they are highly expressed in the endocrine pancreas, which mirrors findings in human islets 22, 24 a r t i c l e s 6 2 0 VOLUME 21 | NUMBER 6 | JUNE 2015 nature medicine (data not shown). Determination of absolute levels of miR-200 family members by quantitative PCR using synthetic miR standards showed that miR-200c had the highest expression in this location ( Supplementary  Fig. 1a ). In normoglycemic obese mice with compensating islet function (high fat diet (HFD)-fed or ob/ob mice, both on the C57BL/6 background), miR-200 levels were lower than or similar to those in WT controls (Fig. 1a) . In db/db mice on the C57BLKS/J background (hereafter referred to as db/db.BLKS), a mouse model that develops uncontrolled diabetes due to impaired beta cell function and augmented apoptosis 25, 26 , levels of miR-200 family members were unchanged or lower at 5 weeks of age compared to age-matched WT mice on the same genetic background. However, miR-200 levels in db/db.BLKS mice were ~3-fold higher than in WT BLKS mice at 12 weeks of age, at which point this strain of mice is profoundly diabetic (Fig. 1b) .
To directly test whether T2D-associated overexpression of miR-200 family members in beta cells is causally linked to beta cell apoptosis, we generated transgenic mice expressing mir-141/200c under the control of the rat insulin promoter. Three founder lines, hereafter referred to as Rip141/200c mice, developed a comparable diabetic phenotype ( Supplementary Fig. 1b,c) , and we selected founder E4 for detailed analysis. Levels of miR-141 and miR-200c were ~4-and ~6-fold higher, respectively, in these mice than in WT littermates, an increase similar to the observed ~3-fold level increase of each miR-200 family member in db/db.BLKS mice (Supplementary Fig. 1d ). Rip141/200c mice developed severe hyperglycemia, which over time resulted in uncontrolled diabetes and associated symptoms (for example, ketoacidosis and reduced fat mass) (Fig. 1c,d and Supplementary  Fig. 1e ). Hyperglycemia was due to a drastic decrease in plasma insulin levels, pancreatic insulin content and beta cell mass (>90% loss in mass at 17 weeks of age) (Fig. 1e-g ), without changes in alpha cell mass (Supplementary Fig. 1f) .
Glucose-stimulated insulin secretion was unaltered in isolated islets of 2-week-old Rip141/200c mice and in beta cell lines after overexpression of miR-200c ( Supplementary Fig. 1g and data not shown). We performed TUNEL staining and found ~6-fold more TUNELpositive apoptotic cells in islets of Rip141/200c mice versus those of WT littermates (Fig. 1h) . In addition, we excluded other potentially viable mechanisms for reduced beta cell mass, including autoimmune destruction, reduced proliferation and beta-to-alpha cell conversion 27 ( Supplementary Fig. 1h-j) .
To address the role of the individual miR-200 family members in the induction of apoptosis, we transfected synthetic mature miRs for all miR-200 family members individually into the mouse beta cell line MIN6. Notably, compared to a control miR, the miRs miR-200b, miR-200c and miR-429 (which share the AAUACUG seed) rapidly induced apoptosis and reduced MIN6 cell counts by 50%, an effect that could be prevented by mutating the seed sequence (Fig. 1i,j) . These data demonstrated that acute and chronic miR-200 overexpression is sufficient to induce beta cell apoptosis and ultimately T2D. Fig. 2b ). We found that mir-141/200c −/− mice were indistinguishable from WT littermates, having Fig. 3a-c Fig. 3d-j) , as well as unaltered expression of beta cell identity markers and no consistent upregulation of EMT markers (Supplementary Table 1 ). Our data indicated that, at least in beta cells, loss of all miR-200 family members neither impaired beta cell function nor induced EMT, which is in line with findings in mice with partial mir-200 ablation 21 or beta cell-specific ablation of the prototypical epithelial marker Cdh1 (ref. 28 ).
miR-200 deficiency protects against beta cell apoptosis Several studies demonstrate that miRs can control vital cellular functions under metabolic stress and thus pathophysiological conditions 29 . To investigate a potential role for the miR-200 family in beta cell demise, we challenged WT, single KO and DKO mice with a low dose of streptozotocin (STZ), an agent known to cause oxidative stress, DNA damage and subsequently beta cell apoptosis and diabetes 2, 26 . STZ thus mimics the oxidative and DNA damage found in islets of diabetic subjects 6 . We monitored plasma glucose levels for 15 d after the last of five (once per day) STZ injections. While WT mice developed fasting hyperglycemia, DKO mice exhibited markedly lower plasma glucose levels (Fig. 2a) Fig. 1a ). Insulin measurements and morphometric analysis of the pancreata revealed that plasma insulin and beta cell mass were ~2-fold and ~3-fold higher, respectively, in DKO mice than in WT mice (Fig. 2b,c) . To investigate if mir-200 ablation prevented STZ-induced beta cell apoptosis, we performed TUNEL staining 3 d after the last STZ injection. At this time point, WT mice were already severely hyperglycemic, 141/200c −/− mice had plasma glucose levels that were strongly reduced, and DKO mice were normoglycemic ( Supplementary Fig. 4a,b) . (Fig. 2d) . Furthermore, histone γ-H2AX, which is phosphorylated in response to oxidative and DNA damage in islets of diabetic db/db.BLKS mice 30 , was ~50% less phosphorylated ( Fig. 2e and Supplementary Fig. 4c ), inflammatory markers were unchanged ( Supplementary Fig. 4d ), and transcript levels of oxidative defense genes such as those encoding the glutathione peroxidases (Gpx1, Gpx3, and Gpx4) and catalase (Cat) were augmented ( Supplementary Fig. 4e ) in islets from STZ-treated DKO mice versus those from STZ-treated WT mice. Proliferation of beta cells was similar in WT and DKO mice at day 8, indicating that protection of beta cells from apoptosis is the initial event in mir-200-deficient mice. At day 20, more beta cell proliferation was present in STZ-treated DKO compared to STZ-treated WT mice ( Supplementary Fig. 4f ), suggestive of additional late-acting protective events. Expression of beta cell identity markers, which is decreased by STZ treatment 31 , remained high in pancreatic islets from DKO as compared to control animals, which may contribute to improved glycemic control (Fig. 2f) .
In a second model of obesity-enhanced beta cell destruction and diabetes, we challenged HFD-induced obese control and DKO mice with a single high-dose (150 mg/kg) administration of STZ (ref. 2). While control animals suffered from massive loss of beta cell mass and diabetes, DKO mice were completely protected against hyperglycemia and beta cell loss ( Fig. 2g-i and Supplementary Fig. 4g-i) .
We next investigated whether loss of miR-200 function is also protective in Akita mice, a well-characterized genetic T2D model in which a spontaneous mutation in the insulin 2 (Ins2) gene causes chronic insulin misfolding, endoplasmatic reticulum stress, pro-apoptotic gene expression and subsequently beta cell apoptosis and diabetes 2, 5 . Much as in the STZ models, we observed ameliorated hyperglycemia, improved plasma insulin levels, augmented beta cell mass (Fig. 3a-d) , higher levels of anti-apoptotic miR-200 targets and lower expression of ER stress markers, including Hspa5 and Ddit3, when miR-200 expression was absent or reduced in these mice ( Supplementary Fig. 5a and Fig. 3e) . In summary, ablation of the miR-200 family inhibited beta cell apoptosis, prevented loss of beta cell mass, improved plasma insulin levels and strongly ameliorated hyperglycemia in multiple diabetic mouse models with hyperactive pathophysiological stress pathways known to be relevant in human diabetes.
miR-200 regulates anti-apoptotic target genes
As mammalian miRs mostly act by destabilizing target mRNAs 32 , we generated transcriptome-wide expression profiles from Rip141/ 200c islets, DKO islets, MIN6 cells with adenoviral overexpression of miR-141/200c and controls (islets from WT littermates and Ad-GFP-expressing MIN6 cells) using Affymetrix arrays and RNA-seq. We confirmed by bioinformatic analyses that overexpression of miR-141/200c in these settings was specific to the miR-141/200c seed sequence and did not affect target gene populations of other relevant miRs, such as miR-7 (ref. 10) (Supplementary Fig. 5b-d) .
We next sought to define the mRNA target(s) of the miR-200 family with prosurvival properties in beta cells. To this end, we set up a series of in vitro and ex vivo experiments in which all candidate mRNAs were assessed. We tested potential targets carrying at least one miR-200c heptamer miR response element (MRE) to determine whether they were decreased in the overexpression or increased in the loss-of-function profiles using expression level and 1.2-fold change cut-offs. From this selection, we first concentrated on candidate targets that were previously associated with beta cell function, apoptosis or ER stress or were linked to T2D risk in genome-wide association studies. In addition we examined candidate genes independent of any previous association with beta cell function or apoptosis that were regulated in at least two of the transcriptome data sets. The criteria above were fulfilled by four mRNAs, encoded by the following genes: the DnaJ (Hsp40) homolog, subfamily C, member 3 gene (Dnajc3), juxtaposed with the JAZF zinc finger 1 gene (Jazf1), the prosurvival ribosomal protein S6 kinase, polypeptide 1 gene (Rps6kb1, also known as p70s6K), and the X-linked inhibitor of apoptosis gene (Xiap). Dnajc3 (also known as p58IPK) is an essential beta cell chaperone, as Dnajc3-deficient mice exhibit spontaneous beta cell apoptosis and develop T2D 33 . JAZF1 harbors a susceptibility locus for T2D in its first intron and shows decreased expression in the beta cells of humans with T2D, although its functional role in beta cells has not yet been addressed 34, 35 . Rps6kb1 is a kinase downstream of mTOR and other growth factor signaling pathways and known to inactivate the pro-apoptotic protein Bad 36, 37 . XIAP binds to and inhibits several caspases including CASP3, and overexpression of XIAP is protective against beta cell stress in both mice and humans, whereas loss of Xiap in mice does not cause an identifiable abnormal phenotype under unstressed conditions [38] [39] [40] .
Alignment of 3′ UTRs of all four genes revealed evolutionarily conserved MREs for miR-200c, indicating that these sequences mediate a basic regulatory function (Supplementary Fig. 5e ). We first confirmed regulation of these genes by qPCR (or by immunoblotting if specific commercial antibodies were available) in an independent set of Rip141/200c islets as well as upon overexpression of miR-200 in mouse beta cells and in human cell line HEK 293 (Fig. 4a-c) . Additionally, we determined that expression of miR-200 targets was higher in DKO than in WT islets (Supplementary Fig. 5f ). We also confirmed target regulation in the Akita mouse model and in human islets when mir-200 was genetically deleted or silenced with antagomirs (anti-miRs), respectively ( Supplementary Figs. 5a  and 6) (Fig. 4d) . Next we used luciferase reporter assays based on luciferase constructs harboring WT or mutated miR-200c MREs sequences in the 3′ UTR to confirm that all four genes were direct targets of miR-200c, but not of miR-141 (Fig. 4e,f) .
As a third step, we transfected two independent siRNAs against all four target genes into beta cell lines and determined their effect on apoptosis. Knockdown of each transcript except that of Xiap induced apoptosis, as determined by cleavage of Casp3, and hence reduced beta cell counts by up to 40% 72 h after transfection (Fig. 4g,h) .
We also investigated if miR-200 regulation of Zeb1, a previously described miR-200 target, might affect the differentiation state of beta cells 23 Table 1 ). Only DKO mice exhibited higher Zeb1 levels and regulation of a restricted subset of EMT markers, including Cdh1 (Supplementary Table 1) , but without any alteration of islet morphology, beta cell function or expression of beta cell identity genes ( Supplementary Fig. 3d-f) . In addition to the genes described above, expression of Dusp26, which encodes dual specificity phosphatase 26, a protein that has been linked to prosurvival signaling 42 , was also strongly reduced (~60%) in Rip141/200c mice and higher in islets of both unstressed and STZ-treated DKO animals (Fig. 5a,b) , which was replicated by acute miR-200c manipulation in mouse and human cells (Figs. 4c and 5c) . To define the role of Dusp26 in beta cells, we silenced Dusp26 by RNA interference, which reduced beta cell counts and induced apoptosis in vitro (Fig. 5d,e) . Dusp26 silencing also induced phosphorylation of the prototypical regulator of apoptosis, Trp53, at Ser15 (Trp53-pSer15) 43 (Fig. 5e) . This post-translational modification is used as a marker for Trp53 activity 43 . Surprisingly, Dusp26 harbors no functional miR-200 MRE, indicating that miR-200 regulated one or more intermediate direct target genes to affect Dusp26 expression. To identify these intermediate target genes, we performed a second screen and found seven genes that were directly targeted by miR-200c and were necessary for full Dusp26 expression ( Supplementary  Fig. 7a,b) . Among them was Ypel2, a potential oncogene of unknown function, which has previously been associated with pancreatic and breast cancer 44 . Ypel2 harbors a conserved and functional miR-200c binding site in its 3′ UTR (Supplementary Fig. 5e ), as confirmed in luciferase reporter assays (Supplementary Fig. 7c,d) . (Supplementary Fig. 7e,f) . Conversely, expression of Ypel2 was higher in islets lacking miR-200 (Supplementary Fig. 5f ). Knockdown of Ypel2 reduced Dusp26 expression (Supplementary Fig. 7g ), stimulated phosphorylation of Trp53-pSer15 (Fig. 5f) , induced Trp53 target gene expression (Fig. 5g) , activated cleavage of Casp3 (Supplementary Fig. 7h ) and reduced beta cell counts (Supplementary Fig. 7i) . We concluded that Dusp26 expression is regulated indirectly by miR-200c through several direct targets including Ypel2. Together, these results indicate that miR-200c regulates prosurvival, anti-apoptosis and ER-stress pathways in parallel through several direct target genes in pancreatic beta cells.
Ypel2 levels were lower in Rip141/200c islets and upon transfection of miR-200c into INS-1E cells in vitro
miR-200 regulates the Trp53 network
We next used an independent and unbiased bioinformatic approach to identify the gene networks that are responsible for miR-200-induced beta cell apoptosis. This analysis, which compared miR-200-regulated Fig. 8a ).
To confirm that Trp53 activity correlates with apoptosis in pancreatic islets of Rip141/200c and STZ-treated DKO mice, we quantified Trp53-pSer15 by immunoblotting and immunohistochemistry. The number of Trp53-pSer15-positive beta cells was ~3-fold higher in Rip141/200c mice, whereas DKO mice exhibited a 70-80% reduction in Trp53-pSer15-positive beta cells compared to STZ-treated controls (Fig. 5h,i) , which was confirmed by measuring protein levels by immunoblot analysis (Fig. 5j and Supplementary Fig. 8b) . Furthermore, acute adenoviral overexpression of miR-200 also potently induced Trp53-pSer15 levels in vitro (Supplementary Fig. 8c ).
Overexpression of miR-200c induced Trp53-regulated transcripts of Bax, Bbc3 (encoding Puma), Pmaip1 (encoding Noxa) and other validated Trp53 targets, including Cdkn1a (encoding P21), Ddit4l (encoding DNA-damage-inducible transcript 4-like), Sulf2 (encoding sulfatase 2) and Phlda3 (encoding pleckstrin homology-like domain, family A, member 3), in islets of Rip141/200c, as compared to that in WT mice (Fig. 6a) . This pro-apoptotic expression pattern was limited to the miR-200b/200c/429 seed sequence ( Supplementary  Fig. 8d) . Previously, strong induction of several Trp53 target genes after STZ treatment was reported 31 . Among those genes, Cdkn1a, Ddit4l, Sulf2 and Phlda3 were reduced in islets from STZ-treated DKO mice (Supplementary Fig. 8e) . Furthermore, inhibition of miR-200c in primary human islets by anti-miRs was sufficient to blunt expression of pro-apoptotic genes induced by diabetes-associated cytokine treatment (Supplementary Fig. 9 )
Treatment with Nutlin-3 (N3), a pharmacological activator of Trp53, confirmed that these genes are under the transcriptional control of Trp3 in beta cells, and N3 treatment induced apoptosis and reduced MIN6 cell counts (data not shown). We observed elevated expression of Atf3 (encoding activating transcription factor 3), Bax, Bbc3, Pmaip1 and Phlda3 in islets from diabetic db/db.BLKS versus WT mice on a BLKS background at the same time as miR-200 induction. This effect was absent or milder in younger, still prediabetic db/db animals, in which miR-200 expression was low (Fig. 6b) . Importantly, Atf3, Bax and Bbc3 are causally linked to mouse beta cell death and are associated with human beta cell apoptosis and diabetes [45] [46] [47] . The role of Phlda3 in beta cells has not been directly studied 48 . A previous report demonstrates that Phlda3 prevents activation of the prosurvival kinase Akt, which is also involved in preventing beta cell death 48, 49 . Notably, we found that overexpression of human Phlda3 was sufficient to induce apoptosis and reduce beta cell counts in vitro (data not shown). Fig. 10a ). In contrast, expression of Atf3, but not of any of the seven Trp53 target genes tested, was profoundly upregulated in STZ-treated Trp53 −/− islets (Supplementary Fig. 10a ).
To directly address whether miR-200c-induced diabetes can be rescued by genetic Trp53 deficiency or inhibition, we bred Rip141/200c mice with either Trp53 −/− mice or Rip-Tag2 mice, which specifically overexpress the Trp53-inhibiting SV40 T antigen in beta cells only 50 . In both settings, the ability of miR-200c to induce its pro-apoptotic gene suite was blunted, and it failed to cause T2D (Fig. 6c-f and Supplementary Fig. 10b,c) . Knockout of the pro-apoptotic B cell lymphoma 2family member Bax, which is crucial for Trp53-induced apoptosis 51 , similarly protected against pancreatic beta cell loss and prevented T2D in Rip141/200c mice (Fig. 6g,h and Supplementary  Fig. 10d ). The extreme glucose intolerance of Rip141/200c mice was ameliorated but not completely rescued when Trp53 or Bax was ablated, indicating that additional (Trp53-and Bax-independent) miR-200-induced deleterious pathways exist (Supplementary Fig. 10e) . Ablation of the gene encoding the pro-apoptotic protein Bad, which is related to Bax and inactivated by Rps6kb1 (refs. 36, 37) , was insufficient to prevent diabetes, underlining the specificity and redundancy of the miR-200 cell death pathways (Fig. 6i-j) .
DISCUSSION
The results presented here underscore the cell type-, cluster-and seedspecific function of the miR-200 family in pancreatic beta cell survival in vivo. Our data demonstrate that miR-200b, miR-200c and miR-429, which share the same seed sequence, are the principal regulators of beta cell apoptosis in pathophysiological models of T2D. Ablation of mir-200c (but not mir-200b and mir-429, which contain identical seed sequences but are expressed at lower copy numbers) partially protects against beta cell demise in response to oxidative and ER stress, while combined ablation of both clusters of the mir-200 family confers the strongest protection against beta cell apoptosis. Therefore, selective pharmacological targeting 52, 53 of the miR-200b/200c/429 seed sequence may be efficacious for protecting beta cells from diabetogenic insults. Importantly, a total loss of mir-200 expression does not result in EMT or cellular dedifferentiation, at least in beta cells (this remains to be tested in other epithelial cell types).
We find that expression of both mir-200 clusters is elevated under diabetic conditions. While several transcription factors, including Trp53 and Txnip, can regulate miR-200 expression 23, 54 , neither acute induction of ER stress, oxidative stress, Trp53 activation nor Trp53 ablation altered miR-200 expression in mouse islets (data not shown), indicating that regulation of miR-200 expression is complex and cell-type specific.
Ablation of mir-200 protects against both oxidative and DNA damage stress (STZ model) and ER stress (Akita model) in vivo, which are known to contribute to beta cell death in rodent and human diabetes [4] [5] [6] . Future studies need to clarify whether miR-200 also mitigates cellular stresses per se. There is clear evidence that the miR-200 family (and probably all miRs) simultaneously target multiple genes and molecular pathways to affect cellular fate 7, 20 , and here we define a network of prosurvival and anti-apoptotic genes that are targeted by the miR-200 family. miR-200 targets Dnajc3, which encodes an established and crucial chaperone in beta cells, and lower Dnajc3 levels may partially explain the higher Atf3 mRNA levels detected upon miR-200 overexpression 33, 55 . Loss of mir-200 also promotes survival by de-repressing Xiap, a potent inhibitor of caspase activation. In this regard, overexpression of XIAP protects human beta cells against apoptosis 38 . Reduced miR-200 activity may also engage other anti-stress and/or prosurvival pathways, for example through JAZF1, a T2D susceptibility locus 34 whose targets and precise mode of action remain to be established. Functional analysis of genetic models with mutations in miR-200 response elements (including the target Zeb1, which contains five miR-200b/200c/429 seed matches in its 3′ UTR 16, 18 ) will help to delineate the relative importance of each target gene.
Our data further indicate that miR-200 modulates the activity of Trp53 through regulation of several direct target genes, most notably Ypel2, which is necessary for full expression of Dusp26, a phosphatase that in turn controls TRP53 (ref. 42) . We therefore propose that during pathophysiological stress conditions mir-200 dosage impacts on several parallel and conserved apoptotic pathways, including ATF3-and TRP53-dependent networks 30, [45] [46] [47] 56 . These findings may not only be relevant in the context of beta cell apoptosis and diabetes. Loss of Trp53 and altered expression of mir-200 are commonly detected in tumorigenesis, and several direct miR-200 targets and executor proteins verified in this study have been linked to tumor formation 44, 57, 58 . Further analysis of their interaction will be informative in regard to endocrine tumor development (for example, insulinoma) and other physiological processes such as postpartum-associated islet remodeling.
In summary, we demonstrate that the miR-200 family is a crucial endogenous regulator of T2D-associated beta cell apoptosis through pleiotropic stress-resistance and prosurvival pathways (Fig. 6j) , and this finding further highlights the crucial influence of miRs on beta cell function [9] [10] [11] [12] . Inhibiting miR-200 activity may be a potential pharmacological strategy to promote beta cell survival.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. Gene Expression Omnibus: Coordinates have been deposited with accession codes GSE58487 (MIN6 cells) and GSE58488 (islets). read end). TopHat was run with default options. The 'fragment length' parameter was set to 100 bases with a standard deviation of 100 bases. On the basis of these alignments, the distribution of the reads across genomic features was assessed. Isoform expression was quantified with the RSEM algorithm 61 with the option for estimation of the read start position distribution turned on. miR expression analysis. 150 ng of total RNA was reverse transcribed using TaqMan MicroRNA Assays (Life Technologies) and TaqMan MicroRNA Reverse Transcription Kit (Life Technologies). The reverse transcription primers were multiplexed in a dilution of 1:20 as described by the manufacturer. Quantitative PCR reactions were performed with the Light Cycler 480 (Roche) employing a 384-well format, TaqMan Universal PCR Master Mix, No AmpErase UNG (Life Technologies) and TaqMan MicroRNA Assays (Life Technologies). Cycles were quantified employing Light Cycler 480 analysis software (Abs quantification/ second derivate max). Relative miR expression was calculated using the ddCT method. For absolute quantification, synthetic miRs (Sigma-Aldrich) were quantified using a NanoDrop ND-1000 spectrophotometer (Thermo Scientific) and the respective molecular weight. miRs were absolutely quantified employing a synthetic miR standard curve.
Seed enrichment analysis. Seed enrichment analysis was performed as published recently using Targetscan 62, 63 .
Human pancreatic islets. Human islets were received from nondiabetic healthy donors. Informed consent was obtained for all subjects. Islets were handpicked and purity was greater than 95%. Human pancreata were harvested from braindead organ donors after obtaining informed consent from family members in agreement with the French Regulations and with Lille's Institutional Ethical Committee (Comité d'Ethique du Centre Hospitalier Régional et Universitaire de Lille) and in accordance the Institutional Review Board of the Departments of Neurology, Dermatology, Anesthesiology and Surgery by delegation of the Institutional Review Board of Geneva University Hospitals. The islet preparation of donors (age range, 21-65; 4 males, 3 females) consisted of 15,000-25,000 islet equivalents with a purity of >80%. All preparations had a viability of >90%. All experiments were performed in five to six technical replicates with islets from individual donors. Pancreatic islets were handpicked under a microscope and cultured in CMRL-1066 medium containing 5.6 mM glucose, 10% FBS, 100 IU/ml penicillin/streptomycin and Glutamax. For target gene expression, islets were cultured for 48 h in the presence of anti-miRs or antagomirs at a concentration of 50 µg/ml, followed RNA extraction using TRIzol. For stressresponse assays, islets were cultured for 24 h in the presence of anti-miRs or antagomirs at a concentration of 50 µg/ml before cytokine/palmitate treatment (in the presence of anti-miRs) for 24 h. Palmitate-conjugated BSA was used at a 1 mM concentration, the cytokine cocktail consisted of IL-1β (50 U/ml), TNF-α (1,000 U/ml) and IFN-γ (1,000 U/ml).
MicroRNA inhibitors. Optimized single-strand modified RNA analogs used in this study were synthesized by Axolabs (Kulmbach, Germany). The term 'antagomirs' refers to cholesterol-conjugated modified RNAs 52 . The term 'antimiRs' refers to unconjugated modified RNAs. Oligonucleotides used in this study consisted of either 23 nucleotides (full-length) or 13 nucleotides, covering the seed sequence, with modifications as specified in Supplementary Table 2. Chemicals. Nutlin-3 (ref. 64) (Sigma-Aldrich) was dissolved in pure DMSO at a concentration of 10 mg/ml (1,000× stock). Tunicamycin (Calbiochem) was dissolved in pure DMSO (stock concentration, 5 mg/ml, 2,500× stock). Etoposide was dissolved in pure DMSO (stock concentration, 25 mM, 500× stock). STZ (Sigma-Aldrich) was dissolved in full medium immediately before use in vitro. Where applicable, DMSO was used as a control.
Statistical analysis.
Numerical values are reported as average ± s.d. unless stated otherwise. Data is derived from multiple independent experiments from distinct mice or cell culture plates, unless stated otherwise. No statistical method was used to predetermine sample size, but sample size was based on preliminary data and previous publications as well as observed effect sizes. Outliers that were two standard deviations outside of the mean were routinely excluded from all analyses. No randomization of animals was performed, but animals were sex-and age-matched, and littermates were used whenever possible. Animal studies were performed without blinding of the investigator. We assessed data for normal distribution and similar variance between groups using GraphPad Prism 6.0 if applicable. Some data sets had a statistical difference in the variation between groups. If not mentioned otherwise in the figure legend, statistical significance (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001) was determined by unpaired two-tailed t-test, or one-way ANOVA with relevant post hoc tests (Tukey's if not specified otherwise). P values and z-scores for signaling networks were determined by Ingenuity software (Qiagen). We used GraphPad Prism 6.0 Software for statistical analysis of all other data sets.
